The current state of iCCM
=========================

Acknowledging a shortage of clinicians and inequitable access to basic health care for many communities in low- and middle-income countries (LMICs), the World Health Organization and United Nations Children\'s Fund developed integrated Community Case Management (iCCM)[@R1]. iCCM is a paper-based clinical decision rule that is deployed by frontline community health workers (CHWs) in hard-to-reach locations. The components of the decision rule are sufficiently simple for CHWs who are educated to secondary school level (with 6 days statutory iCCM training)[@R2] to be able to manage uncomplicated illnesses in the community, and urgently refer seriously ill children to higher-level facilities for more comprehensive medical attention.

Rolled out in the early 2000s[@R3] across Asia and sub-Saharan Africa, iCCM (and its related decision rule, Integrated Management of Childhood Illness (IMCI)) contributed to notable progress towards achieving Millennium Development Goal 4[@R4]. Despite significant reductions in under-5 morbidity and mortality between 1990 and 2015[@R5], the overall impact of iCCM on childhood survival in LMICs is undermined by a variety of factors. These include poor CHW adherence to guidelines[@R6],[@R7], incomplete patient recording, cumbersome monthly aggregation and reporting of cases to district health offices, as well as infrequent training opportunities to retain and develop skills, and irregular supervisory support[@R8]. This has prompted innovative strategies in attempts to optimize iCCM delivery.

The potential of mobile solutions for iCCM
==========================================

Increased affordability and functionality of mobile phones and improved internet/data coverage in sub-Saharan Africa have made them a potential solution for circumventing some of the existing challenges of paper iCCM implementation. Mobile solutions of iCCM have been reported to improve both observed and perceived CHW adherence to iCCM and IMCI guidelines, accuracy of illness classification[@R9],[@R10], and speed of consultation[@R11], when compared to the paper counterparts. Interviews with CHWs and caregivers of sick children have revealed a belief that mobile iCCM improves explanations of treatment recommendations to caregivers[@R12], and could enhance recording of patient visits in village clinic registers[@R13]. Additional perceived benefits include reduced time costs associated with automating aggregation of cases and data submission compared to existing manual procedures, and providing opportunities for more regular feedback and advice from supervisors through exploitation of SMS platforms[@R13],[@R14].

However, existing research evaluating mobile solutions of iCCM is of mixed quality (e.g. few explanatory and confirmatory experimental studies, small sample sizes and observation periods, lack of a control). This casts into question the robustness of the evidence. Some shortcomings may be attributed to methodological choices during study design. But on balance, lack of desired rigor is largely the by-product of inherent imperfections of evaluating a complex intervention in settings where it is difficult to control the influence of extraneous variables[@R15]. Appraising 'quality' is arguably further complicated by the absence of consensus standards for evaluating and reporting mobile health interventions[@R16], and the ongoing contention between hierarchies of evidence and appropriateness[@R17].

Interoperability as the final connection
========================================

A nuance of the 'standards of evidence needed to implement' debate that has received less attention has been a failure to demonstrate, or report on, interoperability of iCCM applications with country-specific district and national health information systems (HIS) (e.g. the DHIS 2)[@R18]. The disease-reporting pathway for iCCM begins with presentation of a sick child for assessment at village clinics and ends when data is available for use by centralized bodies for disease surveillance. Therefore, failure to evaluate connected mobile solutions means interventions for iCCM are only partly being tested under their intended real-world conditions. In LMICs such as Malawi, the ability of CHWs to perform each of the required iCCM steps from assessment through to case reporting precludes standalone evaluation of such mobile solutions for these guidelines. As with most countries, the Malawi Ministry of Health requires a record of every patient visit. Without the ability to send data electronically to local HIS, options for evaluating such interventions may be restricted to the inclusion of both modalities for assessing and treating children under-5.

Several programs of work (in Malawi[@R19] and Uganda[@R20]) have either adopted double assessment and data entry approaches, or have utilized mobile iCCM to direct assessment and data entry into patient records. Whilst it is impossible to speculate on why these procedures were selected in these instances (interoperability may or may not have been the rate limiting step), the authors can identify that lack of interoperability was a crucial determinant of the decision to investigate the added value of a mobile version of iCCM in a feasibility study and clinical trial, as part of the Supporting LIFE program[@R21]. Whilst adding or integrating mobile iCCM with paper iCCM generates some insight into the potential benefits, we have limited understanding of relationships between mobile versions of iCCM and most clinical, process, patient-reported and cost-related outcome measures. Furthermore, without interoperability, or at least cognizance of the challenges of how mobile solutions might be able to work together with existing health IT systems, we have insufficient information to establish their real-world acceptability, feasibility, effectiveness and sustainability locally, as well as their utility in other countries[@R22].

Reasons for failing to integrate mobile solutions of iCCM can be attributed to a mixture of technical, financial, regulatory and local political factors (often hindered by lack of a country-level HIS). This may involve lengthy and complicated negotiations with multiple stakeholders, which may be at odds with external organizations with specific agendas of satisfying funding objectives. In the authors\' case, proving end-to-end functionality with sufficient confidence and in time for standalone evaluation in a clinical trial was not possible.

Interoperability of mobile solutions of iCCM with district and national HIS, needs to be prioritized. Whilst use of both mobile and paper iCCM in the diagnostic work-up of children has been viewed as acceptable to CHWs in previous research[@R13], the practical and financial sustainability of this approach, should be carefully considered. If the standalone potential of these types of interventions is to be truly determined, and a compelling case made for government and investor "buy-in", establishing whether interoperability is achievable needs to be part of programmatic research agendas and supported by local leadership. Exploration of the compatibility and readiness of country-level HIS to support connected systems also warrants investigation. Finally, open architecture more conducive to interoperability is worthy of consideration for leveraging connectedness between programs that are siloed from each other, as well as health systems[@R23].
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